Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Cephalexin

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 64Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Precision BioSciences Gets FDA Fast Track for PBGENE-HBV
    Precision BioSciences Gets FDA Fast Track for PBGENE-HBV

    15 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415414433/en/Precision-BioSciences-Receives-U.S.-FDA-Fast-Track-Designation-for-PBGENE-HBV-a-First-In-Class-Gene-Editing-Therapy-Designed-to-Eliminate-the-Root-Cause-of-Chronic-Hepatitis-B

    BUSINESSWIRE
    15 Apr 2025
    Share Share
    Mission BioCapital Announces 2024 Platinum Ticket Investments
    Mission BioCapital Announces 2024 Platinum Ticket Investments

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mission-biocapital-announces-2024-platinum-ticket-investments-and-opening-of-4-million-2025-platinum-program-contest-302421769.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share
    George Clinical Rebrands as Emerald Clinical Trials
    George Clinical Rebrands as Emerald Clinical Trials

    06 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/george-clinical-rebrands-as-emerald-clinical-trials-302420293.html

    PR NEWSWIRE
    06 Apr 2025
    Share Share
    Vividion Therapeutics Doses First Patient in RAS-PI3K Inhibitor
    Vividion Therapeutics Doses First Patient in RAS-PI3K Inhibitor

    03 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250403585991/en/Vividion-Therapeutics-Doses-First-Patient-in-Phase-I-Study-of-RAS-PI3K-Inhibitor-for-Treatment-of-Advanced-Solid-Tumors

    BUSINESSWIRE
    03 Apr 2025
    Share Share
    Glucotrack Reports 2024 Financial Results and Highlights
    Glucotrack Reports 2024 Financial Results and Highlights

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052830/0/en/Glucotrack-Reports-Full-Year-2024-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Benuvia Operations Awarded NIH Contract for Psilocybin Synthesis
    Benuvia Operations Awarded NIH Contract for Psilocybin Synthesis

    25 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/benuvia-operations-awarded-nih-contract-for-gmp-synthesis-of-psilocybin-and-other-bulk-drug-substances-302409450.html

    PR NEWSWIRE
    25 Mar 2025
    Share Share